IRLAB Therapeutics AB Market Cap

IRLAB Therapeutics AB has a market cap or net worth of 135.90 million as of March 6, 2026. Its market cap has decreased by -81.22% in one year.

Market Cap

135.90M

Enterprise Value

83.99M

Revenue

57.46M

Ranking

n/a

PE Ratio

n/a

Stock Price

1.60

Market Cap Chart

Since February 28, 2017, IRLAB Therapeutics AB's market cap has decreased from 413.00M to 135.90M, a decrease of -67.09%. That is a compound annual growth rate of -11.59%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	135.90M	-18.78%
Dec 30, 2025	167.33M	-69.99%
Dec 30, 2024	557.59M	43.33%
Dec 29, 2023	389.01M	-80.42%
Dec 30, 2022	1.99B	-12.75%
Dec 30, 2021	2.28B	4.76%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
NextCell Pharma AB	147.71M
Xbrane Biopharma AB	123.41M
Simris Group AB (PUBL)	157.93M
Active Biotech AB	115.46M
Magle Chemoswed Holding AB	161.07M
Alligator Bioscience AB	104.66M
Annexin Pharmaceuticals AB	102.36M
Isofol Medical AB	194.67M

Market Cap Rankings